Crescent (CBIO) news

Crescent Biopharma prices offering of shares at $14.50/shr

Crescent Biopharma, Inc. (NASDAQ: CBIO) has priced its recent offering of shares at $14.50 per share. The company, formed through the merger with GlycoMimetics, Inc. in June 2025, continues to advance its lead program, CR-001, a PD-1 x VEGF bispecific antibody, and its pipeline of novel…

Sun Life Global Investments announces June 2026 cash distributions for ETF series

Sun Life Global Investments has announced the June 2026 cash distributions for its exchange-traded series of units of funds (ETF Series) managed by the firm. Unitholders of record on June 22, 2026, will receive distributions for the respective ETF Series, which will be payable on June 29, 2026 .…

CapitaLand Ascendas REIT - acquisition expected to complete by second half of 2026

CapitaLand Ascendas REIT (CLAR) has announced a series of strategic acquisitions expected to be completed by the second half of 2026, further diversifying its global portfolio and enhancing its earnings resilience. These include the acquisition of a 49% interest in a Tier III hyperscale data centre…

Brock Group names Grant Roscoe as COO

Brock Group has announced the appointment of Grant Roscoe as Chief Operating Officer (COO), effective immediately. Roscoe, who is currently the CEO of Crescent, a financial technology company specializing in high-yield business accounts , brings extensive experience in fintech and business…

Important201 people killed, 747 injured in U.S-Israeli attacks that hit 24 provinces - Iranian media citing Red Crescent